The chief sanitary doctor of Ukraine Viktor Lyashko said that the Russian vaccine against coronavirus, which was registered on August 11 and became the first in the world, has not yet passed the third phase of clinical trials. He wrote about this on his Facebook on Wednesday, August 12.
“The Russian Federation has not yet conducted the third phase of clinical trials, which would allow accumulating a sufficient scientific basis for the practical use of the vaccine in humans,” Lyashko wrote.
He also noted that in the third phase of clinical trials, scientists are conducting a placebo-controlled study. According to him, this stage of research usually involves 20 thousand people who receive the vaccine, of which 10 thousand are placebo.
“There is a considerable number of developments in the world that have gone much further than the vaccine developed in the Russian Federation, but awaiting the full completion of tests and WHO prequalification,” the doctor added.
Earlier on the same day, the head of the Russian Ministry of Health, Mikhail Murashko, said that foreign criticism of the Russian vaccine against coronavirus was unfounded and caused by fear of competition. According to him, many countries used forced modes for research, but there was already enough data on the virus to prepare a Russian vaccine.
On August 11, a vaccine based on an adenovirus vector was registered with the Russian Ministry of Health. It became the first registered vaccine against the new coronavirus infection SARS-COV-2 in the world.
All information on the situation with the coronavirus is available on the websites of stopcoronavirus.rf and access vsem.rf. Coronavirus hotline: 8 (800) 2000-112. In addition, information is available under the hashtag #WeWeTogether.